Guobang Pharma Ltd.

¥15.71As of Sun 8 Nov 2026, 12:00 UTC
SSE:605507Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (3.22%)
Div yield 2.73%
ROE 7.40%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.26
PE TTM 19.49
TSR TTM (0.67%)
Mkt cap ¥12.11B
ROIC 9.50%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥20
26.24%
(32.87%)
Hold 4|7|10|5|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.28
0.27
0.27
0.28
7.80%
9.55%
9.81%
4.99%
Revenue¥B
1.598
1.605
1.647
1.600
2.44%
3.06%
6.70%
(1.65%)
Peers (US$1.816B)
Cap (US$)
PE
1.907B
—
1.879B
72.96x
1.761B
66.14x
1.827B
24.12x
Capital
TTM
5Y
10Y
Leveragex
13.13
(0.089)
(0.093)
EBIT/Intx
0.484
0.249
0.241
Own earn%
13.81
416.04
293.08
Sh yield%
31.29
30.69
27.19
Owners
Insiders/Inst%
11.81
36.09
Short interest%
4.87
SBC / revenue%
3.86
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
25–31
$1 testx
0.0
Incr. ROIC%
7